Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30–39 years: a mixed-methods study protocol

Introduction Breast cancer incidence starts to increase exponentially when women reach 30–39 years, hence before they are eligible for breast cancer screening. The introduction of breast cancer risk assessment for this age group could lead to those at higher risk receiving benefits of earlier screen...

Full description

Bibliographic Details
Main Authors: David P French, D Gareth Evans, Juliet A Usher-Smith, Louise Gorman, Sacha J Howell, Sarah Hindmarch
Format: Article
Language:English
Published: BMJ Publishing Group 2024-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/1/e078555.full
_version_ 1826805086953668608
author David P French
D Gareth Evans
Juliet A Usher-Smith
Louise Gorman
Sacha J Howell
Sarah Hindmarch
author_facet David P French
D Gareth Evans
Juliet A Usher-Smith
Louise Gorman
Sacha J Howell
Sarah Hindmarch
author_sort David P French
collection DOAJ
description Introduction Breast cancer incidence starts to increase exponentially when women reach 30–39 years, hence before they are eligible for breast cancer screening. The introduction of breast cancer risk assessment for this age group could lead to those at higher risk receiving benefits of earlier screening and preventive strategies. Currently, risk assessment is limited to women with a family history of breast cancer only. The Breast CANcer Risk Assessment in Younger women (BCAN-RAY) study is evaluating a comprehensive breast cancer risk assessment strategy for women aged 30–39 years incorporating a questionnaire of breast cancer risk factors, low-dose mammography to assess breast density and polygenic risk. This study will assess the feasibility and acceptability of the BCAN-RAY risk assessment strategy.Methods and analysis This study involves women undergoing risk assessment as part of the BCAN-RAY case-control study (n=750). They will be aged 30–39 years without a strong family history of breast cancer and invited to participate via general practice. A comparison of uptake rates by socioeconomic status and ethnicity between women who participated in the BCAN-RAY study and women who declined participation will be conducted. All participants will be asked to complete self-report questionnaires to assess key potential harms including increased state anxiety (State Trait Anxiety Inventory), cancer worry (Lerman Cancer Worry Scale) and satisfaction with the decision to participate (Decision Regret Scale), alongside potential benefits such as feeling more informed about breast cancer risk. A subsample of approximately 24 women (12 at average risk and 12 at increased risk) will additionally participate in semistructured interviews to understand the acceptability of the risk assessment strategy and identify any changes needed to it to increase uptake.Ethics and dissemination Ethical approval was granted by North West—Greater Manchester West Research Ethics Committee (reference: 22/NW/0268). Study results will be disseminated through peer-reviewed journals, conference presentations and charitable organisations.Trial registration number NCT05305963.
first_indexed 2024-03-07T21:54:07Z
format Article
id doaj.art-3d68de653b6d4c9b84809ac5d848fd11
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2025-03-17T02:04:52Z
publishDate 2024-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-3d68de653b6d4c9b84809ac5d848fd112025-02-13T20:00:08ZengBMJ Publishing GroupBMJ Open2044-60552024-01-0114110.1136/bmjopen-2023-078555Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30–39 years: a mixed-methods study protocolDavid P French0D Gareth Evans1Juliet A Usher-Smith2Louise Gorman3Sacha J Howell4Sarah Hindmarch5Manchester Centre for Health Psychology, Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK2 Prevention and Early Detection Theme, NIHR Manchester Biomedical Research Centre, Manchester, UKPrimary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UKNIHR Greater Manchester Patient Safety Research Collaboration, Division of Population Health, Health Services Research & Primary Care, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UKDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UKManchester Centre for Health Psychology, Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UKIntroduction Breast cancer incidence starts to increase exponentially when women reach 30–39 years, hence before they are eligible for breast cancer screening. The introduction of breast cancer risk assessment for this age group could lead to those at higher risk receiving benefits of earlier screening and preventive strategies. Currently, risk assessment is limited to women with a family history of breast cancer only. The Breast CANcer Risk Assessment in Younger women (BCAN-RAY) study is evaluating a comprehensive breast cancer risk assessment strategy for women aged 30–39 years incorporating a questionnaire of breast cancer risk factors, low-dose mammography to assess breast density and polygenic risk. This study will assess the feasibility and acceptability of the BCAN-RAY risk assessment strategy.Methods and analysis This study involves women undergoing risk assessment as part of the BCAN-RAY case-control study (n=750). They will be aged 30–39 years without a strong family history of breast cancer and invited to participate via general practice. A comparison of uptake rates by socioeconomic status and ethnicity between women who participated in the BCAN-RAY study and women who declined participation will be conducted. All participants will be asked to complete self-report questionnaires to assess key potential harms including increased state anxiety (State Trait Anxiety Inventory), cancer worry (Lerman Cancer Worry Scale) and satisfaction with the decision to participate (Decision Regret Scale), alongside potential benefits such as feeling more informed about breast cancer risk. A subsample of approximately 24 women (12 at average risk and 12 at increased risk) will additionally participate in semistructured interviews to understand the acceptability of the risk assessment strategy and identify any changes needed to it to increase uptake.Ethics and dissemination Ethical approval was granted by North West—Greater Manchester West Research Ethics Committee (reference: 22/NW/0268). Study results will be disseminated through peer-reviewed journals, conference presentations and charitable organisations.Trial registration number NCT05305963.https://bmjopen.bmj.com/content/14/1/e078555.full
spellingShingle David P French
D Gareth Evans
Juliet A Usher-Smith
Louise Gorman
Sacha J Howell
Sarah Hindmarch
Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30–39 years: a mixed-methods study protocol
BMJ Open
title Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30–39 years: a mixed-methods study protocol
title_full Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30–39 years: a mixed-methods study protocol
title_fullStr Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30–39 years: a mixed-methods study protocol
title_full_unstemmed Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30–39 years: a mixed-methods study protocol
title_short Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30–39 years: a mixed-methods study protocol
title_sort feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30 39 years a mixed methods study protocol
url https://bmjopen.bmj.com/content/14/1/e078555.full
work_keys_str_mv AT davidpfrench feasibilityandacceptabilityofofferingbreastcancerriskassessmenttogeneralpopulationwomenaged3039yearsamixedmethodsstudyprotocol
AT dgarethevans feasibilityandacceptabilityofofferingbreastcancerriskassessmenttogeneralpopulationwomenaged3039yearsamixedmethodsstudyprotocol
AT julietaushersmith feasibilityandacceptabilityofofferingbreastcancerriskassessmenttogeneralpopulationwomenaged3039yearsamixedmethodsstudyprotocol
AT louisegorman feasibilityandacceptabilityofofferingbreastcancerriskassessmenttogeneralpopulationwomenaged3039yearsamixedmethodsstudyprotocol
AT sachajhowell feasibilityandacceptabilityofofferingbreastcancerriskassessmenttogeneralpopulationwomenaged3039yearsamixedmethodsstudyprotocol
AT sarahhindmarch feasibilityandacceptabilityofofferingbreastcancerriskassessmenttogeneralpopulationwomenaged3039yearsamixedmethodsstudyprotocol